Table 5.
Pharmacological Actions of Glutamate Agents in Animal Models or Paradigms of Psychostimulant Addiction
| N-Acetylcysteine | MPEP | LY379268 | 2-PMPA | AMN082 | |
|---|---|---|---|---|---|
| Pharmacological Actions | Cystine prodrug, glutathione prodrug | mGluR5 antagonist | mGluR2/3 agonist | NAALADase inhibitor | mGluR7 agonist |
| Self-Administration | No effect on cocaine SA | ↓ Cocaine SA (FR, PR) | ↓ Cocaine SA (FR) | ↓ Cocaine SA (PR, notFR) | ↓ Cocaine SA (FR, PR) |
| Reinstatement of Drug-Seeking | ↓ Relapse by cocaine | ↓ Relapse by cocaine, by cues, but not by stress | ↓ Relapse by cocaine or cues | ↓ Relapse by cocaine | ↓ Relapse by cocaine |
| Conditioned Place Preference (CPP) | ↓ CPP by cocaine, amphetamine or MDMA | ↓ CPP by cocaine | |||
| Enhanced Brain-Stimulation Reward (eBSR) | Conflicting | ↓ eBSR by cocaine | ↓ eBSR by cocaine | ||
| Psychostimulant-like Discriminative Stimulus Effects (DS) | ↓ DS by cocaine | ||||
| Behavioral Sensitization (BS) | ↓ BS by cocaine | ↓ BS by cocaine | ↓ BS by amphetamine | ↓ BS by cocaine | |
| Natural Reward | ↓ Food-taking | ↓ Food-seeking | No effect on CPP for food | No effect on sucrose-taking | |
| Clinical Trials | Phase I | No | No | No | No |